These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9666687)

  • 1. [The efficacy of re-TUR after 3 weeks of initial TUR treatment for locally advanced bladder cancer].
    Chiba K; Hirokawa M; Saitoh K; Yumura Y; Saitoh K; Okada Y; Hashiba T; Tomoda T
    Nihon Hinyokika Gakkai Zasshi; 1998 Jun; 89(6):604-8. PubMed ID: 9666687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescence-guided bladder tumour resection: impact on survival after radical cystectomy.
    Gakis G; Ngamsri T; Rausch S; Mischinger J; Todenhöfer T; Schwentner C; Schmid MA; Hassan FA; Renninger M; Stenzl A
    World J Urol; 2015 Oct; 33(10):1429-37. PubMed ID: 25595732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of second transurethral resection on patient outcomes in muscle-invasive bladder cancer patients treated with bladder-preserving multimodal therapy.
    Suer E; Hamidi N; Gokce MI; Gulpinar O; Turkolmez K; Beduk Y; Baltaci S
    World J Urol; 2016 Jun; 34(6):847-51. PubMed ID: 26462931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The results of long-term bladder cancer patient follow-up. The role of TUR in stage T1b and T2 bladder cancers].
    Tsukamoto T; Fujioka T; Hatano T; Nakano H; Ishikawa K; Nagakubo I
    Nihon Hinyokika Gakkai Zasshi; 1994 May; 85(5):760-7. PubMed ID: 8022138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second transurethral resection and prognosis of high-grade non-muscle invasive bladder cancer in patients not receiving bacillus Calmette-Guérin.
    Angulo JC; Palou J; García-Tello A; de Fata FR; Rodríguez O; Villavicencio H
    Actas Urol Esp; 2014 Apr; 38(3):164-71. PubMed ID: 24613147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Staging error in the bladder tumor: the correlation between stage of TUR and cystectomy.
    Bayraktar Z; Gurbuz G; Taşci AI; Sevin G
    Int Urol Nephrol; 2001; 33(4):627-9. PubMed ID: 12452614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of re-transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high-grade/Grade 3 bladder cancer treated with bacille Calmette-Guérin.
    Gontero P; Sylvester R; Pisano F; Joniau S; Oderda M; Serretta V; Larré S; Di Stasi S; Van Rhijn B; Witjes AJ; Grotenhuis AJ; Colombo R; Briganti A; Babjuk M; Soukup V; Malmström PU; Irani J; Malats N; Baniel J; Mano R; Cai T; Cha EK; Ardelt P; Vakarakis J; Bartoletti R; Dalbagni G; Shariat SF; Xylinas E; Karnes RJ; Palou J
    BJU Int; 2016 Jul; 118(1):44-52. PubMed ID: 26469362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results.
    Rödel C; Grabenbauer GG; Kühn R; Papadopoulos T; Dunst J; Meyer M; Schrott KM; Sauer R
    J Clin Oncol; 2002 Jul; 20(14):3061-71. PubMed ID: 12118019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of a second transurethral resection for T1 bladder cancer.
    Schwaibold HE; Sivalingam S; May F; Hartung R
    BJU Int; 2006 Jun; 97(6):1199-201. PubMed ID: 16566814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of high-risk non-muscle invasive bladder cancer.
    Brausi M; Olaru V
    Minerva Urol Nefrol; 2012 Dec; 64(4):255-60. PubMed ID: 23288212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Noninvasive and invasive bladder cancer: diagnostics and treatment].
    Goebell PJ; Vom Dorp F; Rödel C; Frohneberg D; Thüroff JW; Jocham D; Stief C; Roth S; Knüchel R; Schmidt KW; Kausch I; Zaak D; Wiesner C; Miller K; Sauer R; Rübben H
    Urologe A; 2006 Jul; 45(7):873-84; quiz 885. PubMed ID: 16791629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transurethral resection and partial cystectomy for invasive bladder cancer.
    Laufer M
    Semin Urol Oncol; 2000 Nov; 18(4):296-9. PubMed ID: 11101093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A re-staging transurethral resection predicts early progression of superficial bladder cancer.
    Herr HW; Donat SM
    BJU Int; 2006 Jun; 97(6):1194-8. PubMed ID: 16566813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective analysis of transurethral resection, second-look resection, and long-term chemo-metaphylaxis for superficial bladder cancer: indications and efficacy of a differentiated approach.
    Schulze M; Stotz N; Rassweiler J
    J Endourol; 2007 Dec; 21(12):1533-41. PubMed ID: 18186695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant chemotherapy (MVAC) in locally invasive bladder cancer.
    Sagaster P; Flamm J; Flamm M; Mayer A; Donner G; Oberleitner S; Havelec L; Lepsinger L; Ludwig H
    Eur J Cancer; 1996 Jul; 32A(8):1320-4. PubMed ID: 8869093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bladder preservation for locally advanced bladder cancer by transurethral resection, systemic chemotherapy and radiation].
    Honda M; Satoh M; Tujimoto Y; Takada T; Matsumiya K; Fujioka H
    Hinyokika Kiyo; 2006 May; 52(5):331-5. PubMed ID: 16758720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transurethral resection of muscle-invasive bladder cancer: 10-year outcome.
    Herr HW
    J Clin Oncol; 2001 Jan; 19(1):89-93. PubMed ID: 11134199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis and treatment of bladder cancer].
    Lopatkin NA; Darenkov SP; Chernyshev IV; Martov AG; Stupak NV
    Urologiia; 2004; (1):12-7. PubMed ID: 15022437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Conservative treatment of locally advanced bladder carcinoma: neoadjuvant chemotherapy, TUR and radiotherapy. Results in 40 patients].
    Serretta V; Vasile P; Falletta V; Piazza F; Pavone C; Pavone-Macaluso M
    Arch Ital Urol Androl; 1998 Jun; 70(3 Suppl):37-40. PubMed ID: 9707769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.